NeoPharm CO., LTD.

KOSDAQ:A092730 株式レポート

時価総額:₩231.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

NeoPharm 配当金

配当金 基準チェック /26

NeoPharm配当を支払う会社であり、現在の利回りは2.42%で、収益によって十分にカバーされています。

主要情報

2.5%

配当利回り

26%

配当性向

業界平均利回り0.9%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
一株当たり利益₩2.88k
3年後の配当利回り予想2.5%

最近の配当金アップデート

NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Recent updates

NeoPharm CO., LTD. (KOSDAQ:092730) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Jun 13
NeoPharm CO., LTD. (KOSDAQ:092730) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Benign Growth For NeoPharm CO., LTD. (KOSDAQ:092730) Underpins Its Share Price

Apr 24
Benign Growth For NeoPharm CO., LTD. (KOSDAQ:092730) Underpins Its Share Price

NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Mar 25
NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Mar 28
Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Mar 15
What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

How Much Did NeoPharm's(KOSDAQ:092730) Shareholders Earn From Share Price Movements Over The Last Three Years?

Mar 02
How Much Did NeoPharm's(KOSDAQ:092730) Shareholders Earn From Share Price Movements Over The Last Three Years?

We're Watching These Trends At NeoPharm (KOSDAQ:092730)

Feb 18
We're Watching These Trends At NeoPharm (KOSDAQ:092730)

We're Not So Sure You Should Rely on NeoPharm's (KOSDAQ:092730) Statutory Earnings

Feb 08
We're Not So Sure You Should Rely on NeoPharm's (KOSDAQ:092730) Statutory Earnings

NeoPharm CO., LTD. (KOSDAQ:092730) Has Got What It Takes To Be An Attractive Dividend Stock

Jan 26
NeoPharm CO., LTD. (KOSDAQ:092730) Has Got What It Takes To Be An Attractive Dividend Stock

An Intrinsic Calculation For NeoPharm CO., LTD. (KOSDAQ:092730) Suggests It's 31% Undervalued

Jan 15
An Intrinsic Calculation For NeoPharm CO., LTD. (KOSDAQ:092730) Suggests It's 31% Undervalued

Will Weakness in NeoPharm CO., LTD.'s (KOSDAQ:092730) Stock Prove Temporary Given Strong Fundamentals?

Jan 04
Will Weakness in NeoPharm CO., LTD.'s (KOSDAQ:092730) Stock Prove Temporary Given Strong Fundamentals?

NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Dec 15
What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Dec 04
Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Would Shareholders Who Purchased NeoPharm's (KOSDAQ:092730) Stock Year Be Happy With The Share price Today?

Nov 23
Would Shareholders Who Purchased NeoPharm's (KOSDAQ:092730) Stock Year Be Happy With The Share price Today?

決済の安定と成長

配当データの取得

安定した配当: 配当金の支払いは安定していますが、 A092730が配当金を支払っている期間は 10 年未満です。

増加する配当: A092730の配当金は増加していますが、同社は5年間しか配当金を支払っていません。


配当利回り対市場

NeoPharm 配当利回り対市場
A092730 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (A092730)2.5%
市場下位25% (KR)1.0%
市場トップ25% (KR)3.5%
業界平均 (Personal Products)0.9%
3年後のアナリスト予想 (A092730)2.5%

注目すべき配当: A092730の配当金 ( 2.42% ) はKR市場の配当金支払者の下位 25% ( 0.98% ) よりも高くなっています。

高配当: A092730の配当金 ( 2.42% ) はKR市場の配当金支払者の上位 25% ( 3.49% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: A092730の 配当性向 ( 26.1% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。


株主配当金

キャッシュフローカバレッジ: A092730は配当金を支払っていますが、同社にはフリーキャッシュフローがありません。


高配当企業の発掘